Cynata Therapeutics Limited (OTCMKTS:CYYNF – Get Free Report)’s share price dropped 27.4% during mid-day trading on Monday . The stock traded as low as $0.14 and last traded at $0.14. Approximately 3,300 shares changed hands during mid-day trading, an increase of 1,550% from the average daily volume of 200 shares. The stock had previously closed at $0.19.
Cynata Therapeutics Stock Down 27.4 %
The firm’s 50 day moving average price is $0.19 and its 200-day moving average price is $0.19.
About Cynata Therapeutics
Cynata Therapeutics Limited, together with its subsidiaries, develops and commercializes proprietary induced pluripotent stem cell and mesenchymal stem cell technology under the Cymerus brand for human therapeutic use in Australia. The company's lead therapeutic product candidate is CYP-001, which has completed Phase I clinical trial for the treatment of graft versus host disease.
Further Reading
- Five stocks we like better than Cynata Therapeutics
- What is the Nikkei 225 index?
- Build-Your-Bowl Battle: CAVA, Chipotle, and Sweetgreen Face Off
- What is the NASDAQ Stock Exchange?
- Insiders Are Loading Up: 3 Key Stock Picks for Investors
- Low PE Growth Stocks: Unlocking Investment Opportunities
- How Cigna Remains at the Top of the Health Insurance Food Chain
Receive News & Ratings for Cynata Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cynata Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
